Related Experiment Video
Updated: Jun 18, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Sevoflurane: an opportunity for stroke treatment
Jinhui Xu1, Yang Ye, Haitao Shen
1Brain and Nerve Research Laboratory, Department of Neurosurgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China.
Sevoflurane preconditioning and postconditioning show promise in treating ischemic stroke, a leading cause of death and disability. This review explores sevoflurane
Area of Science:
- Neuroscience
- Anesthesiology
- Cardiovascular Research
Background:
- Stroke is a major cause of death and disability, with ischemic stroke being the most common subtype.
- Neurological deficits from ischemic stroke significantly reduce patient quality of life and impose a societal burden.
- Sevoflurane, a modern anesthetic, offers advantages over isoflurane, including faster action and reduced cardiovascular impact.
Purpose of the Study:
- To review the mechanisms of sevoflurane preconditioning and postconditioning in stroke treatment over the past two decades.
- To highlight the potential of sevoflurane as a therapeutic agent for stroke.
Main Methods:
- Literature review of studies on sevoflurane and stroke published in the last 20 years.
- Analysis of the neuroprotective and therapeutic mechanisms of sevoflurane in the context of stroke.
Main Results:
- Sevoflurane preconditioning and postconditioning have demonstrated beneficial effects in stroke models.
- Evidence suggests sevoflurane can mitigate neurological damage associated with ischemic stroke.
Conclusions:
- Sevoflurane exhibits significant therapeutic potential for stroke treatment.
- Further research into sevoflurane's mechanisms in stroke is warranted.
- Sevoflurane may represent a key area for future stroke research and clinical application.
More Related Videos
04:56In Vitro Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells
Published on: October 23, 2018
08:44Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
Published on: September 1, 2016
Related Concept Videos
Inhalational Anesthetics: Overview
Parenteral Anesthetics: Overview